Russia To Supply 100 mn Doses Of Sputnik COVID Vaccine To India’s Dr Reddy, Inks Pact tribuneindia.com

Deliveries could begin in late 2020 subject to completion of successful trials, registration of vaccine by regulatory authorities The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd (Dr. Reddy’s), a global pharmaceutical company headquartered out of India, on Wednesday agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.